Hans Lundin is Specifica’s CFO. Hans has over 20 years of experience as a CFO in entrepreneurial and venture capital settings. Responsibilities include operations, financial modeling, budgeting mergers and acquisitions negotiations, audit compliance, investment syndications and management, board participation, portfolio management, portfolio company interim CEO and CFO consulting, GAAP and tax accounting, federal regulatory compliance, private securities valuation, investor relations, and fund raising.
Hans also works for Point B Capital on strategic financial advisory projects. He has completed engagements for entities including Mars, MolsonCoors, the Seattle Cancer Care Alliance, Sutter Health, OncoCyte, the PolyClinic, BloodWorks Northwest, the Wisconsin Alumni Research Fund, and others. Prior to joining Point B Capital, he was a co-founder of Integra Ventures, a life science VC fund. He was also part of a founding management team for an agricultural biotechnology company that raised over $14 million of venture capital from an investor syndicate that included Venrock, Arch, Polaris and the Welcome Trust.
Hans has served on the boards of Clear Medical (acquired by Stericycle in 2011), Wellpartner (acquired by CVS Health in 2017) and C-SATS (acquired by Johnson & Johnson in 2018).
He has a Bachelor of Science in management from the U.S. Coast Guard Academy and earned his Master of Business Administration at the University of Colorado.